Severe hypocalcemia and life-threatening ventricular arrhytmias: case report and proposal of a diagnostic and
Emanuele Cecchi1, Francesco Grossi1, Matteo Rossi2
1Cardiac Step-Down Unit, Department of Heart and Vessels, Careggi Hospital and University of Florence, Florence, Italy.
Insights
Severe hypocalcemia can cause dangerous heart rhythms, especially in patients with kidney problems. Prompt treatment and collaboration between heart and hormone specialists are key for managing this electrolyte imbalance.
Area of Science:
- Cardiology
- Endocrinology
- Nephrology
Background:
- Hypocalcemia is common in patients with endocrine disorders, bone diseases, and renal failure.
- Severe hypocalcemia poses a risk for life-threatening ventricular arrhythmias.
- Prompt hospital admission and electrolyte correction are crucial for severe cases.
Abstract:
Hypocalcemia is frequent in the setting of endocrine disorders, bone diseases and renal failure. When hypocalcemia is severe it can predispose to life-threatening ventricular arrhythmias; in such cases a rapid admission to hospital and a prompt correction of electrolyte imbalance are needed. We report the case of an old patient suffering from renal failure that was admitted to our cardiac step-down unit because of severe hypocalcemia associated with ventricular arrhythmias. Hypocalcemia was promptly treated and an endocrinologic consult was requested for investigating the causes of this electrolyte imbalance. Our experience suggests the creation of a new synergy between cardiologists and endocrinologists that led us to build a simple and schematic algorithm for the diagnosis and treatment of hypocalcemia.
More Related Videos
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias VII: Nursing Management of Dysrhythmias
Dysrhythmias V: Evaluating Dysrhythmias
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...


